Babcock & Wilcox (BW) has disclosed a new risk, in the Accounting & Financial Operations category.
Babcock & Wilcox faces a significant business risk due to identified material weaknesses in internal control over financial reporting, as revealed in their annual report. The ineffectiveness of these controls, as of year-end 2023, raises concerns about the potential for material misstatements in financial statements and the timely detection of such errors. This situation could lead to regulatory scrutiny, sanctions, and challenges in maintaining NYSE listing standards, which in turn might adversely affect the company’s business prospects and stock valuation.
Overall, Wall Street has a Moderate Buy consensus rating on BW stock based on 1 Buy and 1 Hold.
To learn more about Babcock & Wilcox’s risk factors, click here.
